Private Sector Malaria Case Management in Cambodia: ACTwatch Findings 2015

2002: Private sector

social marketing of

ACT & mRDT

2009: MoH bans

artemisinin

monotherapies

2000: ASMQ is

first-line treatment

2010: DHA PPQ is

first-line treatment

2011: Increased private sector

regulation through public private

partnership program (PPM)

2011-2012: PPM

pilot expansion with

CNM & URC

2015: ASMQ is first-line

treatment in areas with

treatment failure

2014: 2,010 licensed

private providers are

enrolled in PPM

Outlets with a completed patient observation & interview:

18% of

patients

present at

the outlet

were tested

for malaria

Most outlets were in the regulated private sector (private for-profit health centers &

pharmacies), but nearly a quarter of outlets were in the unregulated private sector (drug

stores & itinerant drug vendors). The majority of outlets were in Tier 1 provinces.

N = 220Pharmacy

Drug Store

Itinerant Drug Vendor

Private for-Profit

Health Facility

Tier 1

Tier 2

Outlet

Type

Outlet

Location

0

10

20

30

40

50

60

70

80

90

100

Itinerant

Drug Vendor*

Private for-

Profit Facility

Drug Store Pharmacy 15-24

years*

25-34

years*

35-49

years

50+ years Male* Female Forest

Worker*

Other

Occupation

Outlet Type Patient Age Patient Sex Patient Occupation

PE

RC

EN

T O

F P

AT

IEN

TS

Proportion of patients who received a malaria blood test:

Malaria blood testing was highest among male

patients, patients aged 15-34, patients seeking

care with itinerant drug vendors, & patients who

reported forest work as their occupation.

Patient

Age

Patient

Sex

Patients with a completed observation & interview:

25-34 years

35-49 years

50+ years

15-24 years

Unknown

Female

Male

Distribution of patient age & sex did not differ significantly across

outlet type, but a higher proportion of patients seeking care at

itinerant drug vendors reported forest work (20%) compared to other

outlet types.

Malaria test results & treatments dispensed:

of patients were present at the outlet at the time of consultation. The other 20% were not present, with care being sought by a caregiver on the patient’s behalf.80%

7 tested (+)

for malaria

5 received DHA PPQ

1 received prescription for chloroquine

1 received referral to public sector

23 tested (-)

for malaria23 did not receive an antimalarial

189 not tested

for malaria1 received DHA PPQ